Company news
TheraCryf PLC news in 2016
TheraCryf PLC's news releases, calls and decks from 2016, newest first.
Half Yearly Report
December 5, 2016
Hardman Research: Clinical sulforaphane potential
November 29, 2016
Notice of Interim Results
November 17, 2016
Update re SFX-01 Data at ECTRIMS 2016
September 15, 2016
Presentation of SFX-01 Data at ECTRIMS 2016
September 8, 2016
Orphan Designation in the USA in SAH
August 24, 2016
Approval for Phase II Study in Breast Cancer
August 17, 2016
First Patient Dosed in Phase II Trial
May 3, 2016
Approval of Phase II Clinical Trial in SAH
March 2, 2016
Correction: Director Share Purchases
January 19, 2016
Exercise of Options
January 11, 2016
Appoints Chief Medical Officer
January 4, 2016